Full-Time

Supervisor

AIC and Practitioner Credentialing

Posted on 10/31/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$62.4k - $104k/yr

+ Pay Range is $62,386.44-$103,999.91

Chicago, IL, USA

In Person

Category
Operations & Logistics (3)
, ,
Requirements
  • Bachelors’ Degree and at least 3 years experience working with or for third party payors in the healthcare industry in the areas of credentialing or contract administration, OR High school diploma/GED and at least five (5) years’ experience working with medical providers or payors in the healthcare industry in the areas of credentialing or contract administration.
  • Experience with Provider credentialing application completion or Request for Proposal work in the medical field.
  • Experience using time management skills such as prioritizing/organizing and tracking details and meeting deadlines of multiple projects with varying completion dates.
  • Experience building and maintaining excellent internal and external working relationships.
  • Experience generating, analyzing, and presenting sales opportunity and activity reports for management.
  • Intermediate level skill in Microsoft Word (for example: creating and modifying text styles, numbering and sorting lists, working with sections and columns, formatting tables, and using templates and using diagrams and drawing tools)
  • Intermediate level skill in Microsoft Excel (for example: formatting text and borders of cells, working with workbooks and worksheets, using range names, referencing cells, sorting, and auto filtering).
  • Intermediate level skill in Microsoft PowerPoint (for example: applying a theme, formatting character spacing, inserting a picture, changing slide layout and theme colors, adding transitions, customizing slide numbers, changing chart style and/or formatting font)
Responsibilities
  • Responsible for the completion and management of credentialing and attestation documents required by AIC Payers for execution of contracts and continued services by Option Care Co. Creates and maintains information in databases ensuring all deadlines are met and content is accurate and complete as required to maintain good standing with third party contract partners.
  • Mentors and coaches other Specialist team members, teaching OCH systems, credentialing process, best practices, etc.
  • Collaborate with Facilities, Directors of Operations, Legal, Compliance, and Provider Enrollment legal team, corporate clinical team, Quality and Accreditation Manager, and other internal departments to ensure accurate documentation and details of completion of credentialing and attestations are in compliance with our licensure, policies, and procedures
  • Tracks and monitors AIC contracts throughout their lifecycle from inception to execution and post-implementation; maintains knowledge of status and information within contracts; facilitates the routing, approval, and execution of third party Payor contracts, and compiles all executive summary documents to present for review including contract and credentialing documents, financial models, Legal and Operational review comments, issue memos, etc.
  • Participates in the development and maintenance of AIC contract tracking and routing processes to ensure timely follow up with various departments regarding contract status with the end result being the deployment of an electronic Contract Management System; Monitors contracts throughout their lifecycle from inception to execution and post-implementation, and maintains knowledge of status and information within contracts; Communicates status of contracts to various Option Care Co. departments and executives as appropriate.
  • Assists in managing department inbox to appropriately triage communications from internal and external customers.
  • Provides necessary support and communication to all internal Option Care Co. personnel regarding day to day AIC sales, service, operations, and contracting functions, as well as support ad-hoc AIC projects, requests, and initiatives.
  • Collects and tracks contract management performance, as well as maintains demographic information for all contracted Option Care pharmacies.
  • Maintains pipeline list of Contract Director/Manager activity and new business wins for department.Analyzes reports and prepares presentation of results for management
  • Coordinates with Sales, Contracting, Legal, and other internal departments to ensure consistent communication of AIC issues related to each client/Payor contract and reports specific details as requested or necessary to monitor contract performance.
  • Coordinates efforts of the VP and Contract Directors/Managers for business within the sales territory.
  • Coordinates sales meetings as directed by management
Desired Qualifications
  • Bachelor’s Degree and at least four (4) years Home Infusion, Respiratory Services, and/or Specialty Pharmacy contract coordination and administration experience.
  • At least (1) year of supervisory experience.
  • At least three (3) years payor and facility credentialing experience
  • At least three (3) years experience performing healthcare contract coordination or administration or paralegal experience.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Analyst price targets up to $40.09 suggest 46% upside from May levels.
  • Expanded $850M credit facility enables M&A consolidation in fragmented market.
  • Management projects $7B revenue by 2029 assuming CID reset normalizes.

What critics are saying

  • Chronic Inflammatory Disease portfolio headwind of $55M persists beyond 2026.
  • Revenue growth slowed to 1.1% versus historical 12% and industry 4.7%.
  • Biosimilar conversions and IRA headwinds compress margins $25–35M annually through 2027.

What makes Option Care Health unique

  • Largest independent home infusion provider with 315,000+ unique patients served.
  • 40% of claims processed without human intervention via automation investments.
  • Diversified portfolio across acute, chronic, and immunoglobulin neurology therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE